Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
»
ASCO: Pfizer, chasing full approval conversion for Braftovi combo, touts 'unprecedented' survival win
Fierce Pharma
Fri, 05/30/25 - 11:25 am
ASCO 2025
Pfizer
Braftovi
clinical trials
metastatic colorectal cancer
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
BioPharma Dive
Fri, 05/30/25 - 11:23 am
Regeneron
Sanofi
COPD
clinical trials
itepekimab
Illumina introduces a new AI algorithm PromoterAI: Stock to gain?
Yahoo/Zacks.com
Fri, 05/30/25 - 11:53 am
Illumina
diagnostics
Medtech
PromoterAI
artificial intelligence
How the GOP megabill may roll back the Affordable Care Act
Axios
Fri, 05/30/25 - 11:15 am
legislation
Donald Trump
ACA
Affordable Card Act
A new Covid variant could drive up summer cases
NBC News
Fri, 05/30/25 - 11:13 am
WHO
COVID-19
Public Health
As Austedo, Ajovy and Uzedy gain steam, Teva banks on $5B-plus in 2030 innovative drug sales
Fierce Pharma
Fri, 05/30/25 - 11:11 am
Teva Pharmaceutical
Austedo
Ajovy
Uzedy
AbbVie’s ADC win shows how pharma can break through in solid tumors
Pharma Voice
Fri, 05/30/25 - 11:09 am
AbbVie
antibody-drug conjugates
solid tumors
FDA
Emrelis
Astellas aspires to strike CLDN18.2 gold again with ADC licensing deal worth up to $1.34B
Fierce Biotech
Thu, 05/29/25 - 10:47 pm
Astellas
solid tumors
antibody-drug conjugates
Trump administration report on US child health cited nonexistent studies, media report says
Yahoo/Reuters
Thu, 05/29/25 - 10:42 pm
HHS
Donald Trump
Public Health
Robert F Kennedy Jr.
Pfizer and Arvinas gamble to shift breast cancer treatment paradigm
Clinical Trials Arena
Thu, 05/29/25 - 10:38 pm
Pfizer
Arvinas
breast cancer
vepdegestrant
CVS Sues Arkansas Over Law Banning PBM Ownership Of Pharmacies
Forbes
Thu, 05/29/25 - 10:37 pm
CVS Health
Arkansas
legal
PBMs
Optive AI Gets FDA Clearance, Elevates Image Quality for Swoop Portable MRI
Xtalks
Thu, 05/29/25 - 07:08 pm
Medtech
Optive AI
Hyperfine
brain imaging
FDA
May 29 2025 - Drugmakers, trade groups and others voice concerns with pharma-specific tariffs
Thu, 05/29/25 - 11:23 am
Drugmakers, trade groups and others voice concerns with pharma-specific tariffs
Fierce Pharma
Thu, 05/29/25 - 11:18 am
Donald Trump
tariffs
drug pricing
pharma industry
Boston Scientific pulls plug on TAVR devices after failing to gain FDA approval
Cardiovascular Business
Thu, 05/29/25 - 11:15 am
Medtech
Boston Scientific
Acurate Neo 2
Acurate Prime
TAVR
FDA
Intellia's stock sinks on gene therapy patient's raised enzyme levels, but analysts keep faith
Fierce Biotech
Thu, 05/29/25 - 11:11 am
Intellia Therapeutics
clinical trials
gene therapy
nex-z
transthyretin amyloid cardiomyopathy
Stealth hit by FDA rejection to twice-delayed filing as it lays off staff
Fierce Biotech
Thu, 05/29/25 - 11:08 am
Stealth BioTherapeutics
layoffs
FDA
Rare Diseases
Illumina widens access to cancer tests with Medicare and new CDx
Medical Device Network
Thu, 05/29/25 - 11:05 am
Medtech
diagostics
Illumina
Medicare
oncology
FDA approves Alcon’s Tryptyr (AR-15512) for signs and symptoms of dry eye disease
Ophthalmology Times
Thu, 05/29/25 - 11:00 am
Alcon
FDA
Tryptyr
dry eye disease
The medtech IPO window is finally open. Or is it?
Medtech Dive
Thu, 05/29/25 - 10:58 am
Medtech
IPOs
Ceribell
Beta Bionics
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »